We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tongxinluo and Functional Outcomes Among Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
- Authors
Dong, Yi; Jiang, Kaifu; Li, Zhenguang; Zhou, Yanhua; Ju, Bo; Min, Lianqiu; He, Qiu; Fan, Ping; Hu, Wenli; Qu, Hongdang; Wu, Haiqin; Pan, Chunlian; Cao, Yibing; Lou, Xiaoliang; Zhang, Guiru; Zhang, Jiewen; Hu, Fengyun; Dong, Qiang; TISS Trial Investigators
- Abstract
Previous studies revealed limited effectiveness of neuroprotective agents in treating acute ischemic stroke (AIS). Tongxinluo, developed from traditional Chinese medicines, has been recognized as a novel neuroprotective agent with anti-inflammatory properties that stabilize vulnerable plaques in animal models and patients with myocardial infarction.
- Publication
JAMA network open, 2024, Vol 7, Issue 9, pe2433463
- ISSN
2574-3805
- Publication type
Journal Article
- DOI
10.1001/jamanetworkopen.2024.33463